Principles and Procedures of Human Immunodeficiency Virus Serodiagnosis

作者:

DOI: 10.1128/9781555815905.CH94

关键词:

摘要: An important early impetus for the development and testing of serologic methods to detect human immunodeficiency virus (HIV) infection was need guarantee safety blood supply. A quick review statistics provided in this chapter makes clear continued methods, including point-of-care testing, that are useful especially resource-poor settings. The standard screening tests HIV involve detection HIV-specific antibodies. enzyme-linked immunosorbent assay (ELISA) is test HIV-1 infection. Individuals with indeterminate or positive ELISA results should undergo confirmation (generally by Western blotting [immunoblotting]) determine if reactivity primarily directed secondarily cross-reacting It has now become practice banks screen donated samples one new HIV-1-HIV-2 combination ELISAs. major core protein p24. p24 antigen been used many years prognostic staging management infected individuals licensed United States as part routine donor screening. Serologic assays antibodies most widely means laboratory diagnosis Most algorithms include an component confirmatory method.

参考文章(37)
Arlene King, Stephen A Marion, Darrel Cook, Michael Rekart, Peter J Middleton, MV O’Shaughnessy, JSG Montaner, None, Accuracy of a saliva test for HIV antibody. Journal of Acquired Immune Deficiency Syndromes. ,vol. 9, pp. 172- 175 ,(1995)
Jeffrey P. Iltis, Navin M. Patel, Stephen R. Lee, Scott L. Barmat, William C. Wallen, Comparative evaluation of an immunofluorescent antibody test, enzyme immunoassay and western blot for the detection of HIV-1 antibody. Intervirology. ,vol. 31, pp. 122- 128 ,(1990) , 10.1159/000150146
B B Kvinesdal, C M Nielsen, A G Poulsen, N Højlyng, Immunofluorescence assay for detection of antibodies to human immunodeficiency virus type 2. Journal of Clinical Microbiology. ,vol. 27, pp. 2502- 2504 ,(1989) , 10.1128/JCM.27.11.2502-2504.1989
B. M. Branson, Point‐of‐Care Rapid Tests for HIV Antibodies Laboratoriums Medizin. ,vol. 27, pp. 288- 295 ,(2003) , 10.1046/J.1439-0477.2003.03049.X
E. M. Walker, A. A. Pappas, Houn-Yee Houn, Status of current clinical tests for human immunodeficiency virus (HIV): applications and limitations. Annals of Clinical and Laboratory Science. ,vol. 17, pp. 279- 285 ,(1987)
Bernard Weber, El Hadji Mbargane Fall, Annemarie Berger, Hans Wilhelm Doerr, Reduction of Diagnostic Window by New Fourth-Generation Human Immunodeficiency Virus Screening Assays Journal of Clinical Microbiology. ,vol. 36, pp. 2235- 2239 ,(1998) , 10.1128/JCM.36.8.2235-2239.1998
Jörg Schüpbach, Jürg Böni, Quantitative and sensitive detection of immune-complexed and free HIV antigen after boiling of serum Journal of Virological Methods. ,vol. 43, pp. 247- 256 ,(1993) , 10.1016/0166-0934(93)90080-B
J M Lange, D A Paul, H G Huisman, F de Wolf, H van den Berg, R A Coutinho, S A Danner, J van der Noordaa, J Goudsmit, Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS. BMJ. ,vol. 293, pp. 1459- 1462 ,(1986) , 10.1136/BMJ.293.6560.1459
I. Loussert-Ajaka, F. Brun-Vézinet, F. Simon, T.D. Ly, M.L. Chaix, S. Saragosti, A.M. Couroucé, D. Ingrand, HIV-1/HIV-2 seronegativity in HIV-1 subtype 0 infected patients The Lancet. ,vol. 343, pp. 1393- 1394 ,(1994) , 10.1016/S0140-6736(94)92524-0